Gerstmann-Sträussler-Scheinker disease revisited: accumulation of covalently-linked multimers of internal prion protein fragments

[1]  K. Blennow,et al.  Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain. , 2019, Brain : a journal of neurology.

[2]  B. Caughey,et al.  The prion 2018 round tables (I): the structure of PrPSc , 2019, Prion.

[3]  B. Sykes,et al.  A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles , 2018, PLoS pathogens.

[4]  C. Jaroniec,et al.  Species-dependent structural polymorphism of Y145Stop prion protein amyloid revealed by solid-state NMR spectroscopy , 2017, Nature Communications.

[5]  C. Sigurdson,et al.  Post-translational modifications in PrP expand the conformational diversity of prions in vivo , 2017, Scientific Reports.

[6]  B. Ghetti,et al.  Novel strain properties distinguishing sporadic prion diseases sharing prion protein genotype and prion type , 2017, Scientific Reports.

[7]  Youssra K Al-Hilaly,et al.  The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson’s disease , 2016, Scientific Reports.

[8]  W. Surewicz,et al.  Amyloid fibrils from the N-terminal prion protein fragment are infectious , 2016, Proceedings of the National Academy of Sciences.

[9]  M. van Heel,et al.  The Structural Architecture of an Infectious Mammalian Prion Using Electron Cryomicroscopy , 2016, PLoS pathogens.

[10]  B. Ghetti,et al.  Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases , 2016, Scientific Reports.

[11]  Wei Chen,et al.  Structural Determinants of Phenotypic Diversity and Replication Rate of Human Prions , 2015, PLoS pathogens.

[12]  Thomas L. Williams,et al.  A central role for dityrosine crosslinking of Amyloid-β in Alzheimer’s disease , 2013, Acta neuropathologica communications.

[13]  Jonathan A. Fauerbach,et al.  Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals. , 2012, Free radical biology & medicine.

[14]  Bernhard Kuster,et al.  Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present , 2012, Analytical and Bioanalytical Chemistry.

[15]  I. Zerr,et al.  Sporadic Creutzfeldt-Jakob disease. , 2011 .

[16]  M. Bishop,et al.  Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties , 2010, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Greenspan,et al.  PrP Conformational Transitions Alter Species Preference of a PrP-specific Antibody* , 2010, The Journal of Biological Chemistry.

[18]  B. Ghetti,et al.  Characterization of Truncated Forms of Abnormal Prion Protein in Creutzfeldt-Jakob Disease* , 2008, Journal of Biological Chemistry.

[19]  M. Mann,et al.  In-gel digestion for mass spectrometric characterization of proteins and proteomes , 2006, Nature Protocols.

[20]  J. Langeveld,et al.  Immunological characterization of abnormal prion protein from atypical scrapie cases in sheep using a panel of monoclonal antibodies. , 2006, The Journal of general virology.

[21]  B. Ghetti,et al.  Gerstmann-Sträussler-Scheinker: A New Phenotype With 'Curly' PrP Deposits , 2006, Journal of neuropathology and experimental neurology.

[22]  S. Simon,et al.  Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells* , 2005, Journal of Biological Chemistry.

[23]  Shu G. Chen,et al.  Identification of Novel Proteinase K-resistant C-terminal Fragments of PrP in Creutzfeldt-Jakob Disease* , 2003, Journal of Biological Chemistry.

[24]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[25]  B. Ghetti,et al.  Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. , 2001, The American journal of pathology.

[26]  B. Ghetti,et al.  A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V* , 2001, The Journal of Biological Chemistry.

[27]  B. Ghetti,et al.  Genetic influence on the structural variations of the abnormal prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Surewicz,et al.  Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. , 2000, Journal of molecular biology.

[29]  B. Giasson,et al.  Dityrosine cross-linking promotes formation of stable α-synuclein polymers , 2000, Neurobiology of Aging.

[30]  A. Buschmann,et al.  A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. , 1999, Virology.

[31]  H. Budka,et al.  Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Chesebro,et al.  A 60-kDa Prion Protein (PrP) with Properties of Both the Normal and Scrapie-associated Forms of PrP (*) , 1995, The Journal of Biological Chemistry.

[33]  B. Ghetti,et al.  Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish Kindreds) express only PrP peptides encoded by the mutant allele , 1994, Cell.

[34]  S. Prusiner.  Inherited prion diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Prusiner,et al.  Amyloid protein of Gerstmann‐Sträussler‐Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N‐terminal glycine at codon 58. , 1991, The EMBO journal.

[36]  H. Wiśniewski,et al.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.

[37]  A. Marmorstein,et al.  Isolation and structural studies of the intact scrapie agent protein. , 1987, Archives of biochemistry and biophysics.

[38]  S. Prusiner,et al.  Scrapie PrP 27-30 is a sialoglycoprotein , 1985, Journal of virology.

[39]  G. Kovacs,et al.  Genetic Creutzfeldt-Jakob disease. , 2018, Handbook of clinical neurology.

[40]  B. Ghetti,et al.  Dominantly inherited prion protein cerebral amyloidoses - a modern view of Gerstmann-Sträussler-Scheinker. , 2018, Handbook of clinical neurology.

[41]  W. Surewicz,et al.  Molecular biology and pathology of prion strains in sporadic human prion diseases , 2010, Acta Neuropathologica.